What does CUSIP 64125C109 represent in this 13F holders report?

CUSIP 64125C109 is the security identifier for NBIX - Neurocrine Biosciences Inc - Common Stock used to aggregate holder disclosures.

How many institutions held NBIX - Neurocrine Biosciences Inc - Common Stock in Q4 2023?

545 institutional investors reported NBIX - Neurocrine Biosciences Inc - Common Stock for Q4 2023. Use the holders table for investor-level position and value details.

Neurocrine Biosciences Inc - Common Stock (NBIX)

CUSIP: 64125C109

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock
Shares outstanding: 100,534,245
Total 13F shares: 92,326,586
Share change: -158,416
Total reported value: $12,160,216,767
Put/Call ratio: 80%
Price per share: $131.76
Number of holders: 545
Value change: +$5,244,067
Number of buys: 268
Number of sells: 242

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - Neurocrine Biosciences Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 64125C109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NBIX - Neurocrine Biosciences Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	13%	13,371,398	$1,504,282,281	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	9.5%	9,559,843	$1,075,482,337	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	3.8%	3,836,507	$431,607,038	—	30 Sep 2023	13F
Bellevue Group AG	13F	Company	2.6%	2,583,550	$290,649,375	—	30 Sep 2023	13F
Point72 Asset Management, L.P.	13F	Company	2.6%	2,578,128	$290,039,400	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	1.9%	1,924,079	$216,459,192	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	1.8%	1,811,237	$203,764,179	—	30 Sep 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.7%	1,717,054	$193,169,665	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.6%	1,590,164	$178,893,000	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	1,554,630	$174,679,377	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	1.5%	1,539,392	$173,181,630	—	30 Sep 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.3%	1,327,939	$149,393,139	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.3%	1,268,266	$142,679,925	—	30 Sep 2023	13F
Rock Springs Capital Management LP	13F	Company	1.2%	1,236,000	$139,050,000	—	30 Sep 2023	13F
DSM CAPITAL PARTNERS LLC	13F	Company	1.2%	1,224,017	$137,701,913	—	30 Sep 2023	13F
ARMISTICE CAPITAL, LLC	13F	Company	1.2%	1,216,365	$136,841,063	—	30 Sep 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.2%	1,209,714	$136,092,825	—	30 Sep 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.2%	1,179,650	$132,711,000	—	30 Sep 2023	13F
BROWN ADVISORY INC	13F	Company	1.1%	1,089,582	$122,577,934	—	30 Sep 2023	13F
Pictet Asset Management Holding SA	13F	Company	1%	1,043,450	$117,388,125	—	30 Sep 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	1%	1,013,744	$114,046,200	—	30 Sep 2023	13F
BRAIDWELL LP	13F	Company	0.96%	968,024	$108,902,700	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.84%	843,343	$94,876,088	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.78%	786,955	$88,532,438	—	30 Sep 2023	13F
FRANKLIN RESOURCES INC	13F	Company	0.76%	766,186	$86,195,926	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.73%	736,207	$82,823,288	—	30 Sep 2023	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.72%	727,279	$81,818,887	—	30 Sep 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.69%	692,374	$77,892,075	—	30 Sep 2023	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.67%	678,330	$76,312,000	—	30 Sep 2023	13F
Avidity Partners Management LP	13F	Company	0.65%	652,100	$73,361,250	—	30 Sep 2023	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.65%	649,292	$73,045,350	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.62%	623,267	$70,117,538	—	30 Sep 2023	13F
VIRGINIA RETIREMENT SYSTEMS ET Al	13F	Company	0.6%	600,823	$67,592,588	—	30 Sep 2023	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.59%	591,985	$66,598,313	—	30 Sep 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.59%	589,291	$66,295,241	—	30 Sep 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.58%	584,539	$65,760,638	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.56%	559,771	$62,974,238	—	30 Sep 2023	13F
GW&K Investment Management, LLC	13F	Company	0.55%	554,791	$62,414,000	—	30 Sep 2023	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.55%	553,405	$62,258,063	—	30 Sep 2023	13F
Fiera Capital Corp	13F	Company	0.51%	511,368	$57,528,900	—	30 Sep 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.5%	498,589	$56,091,271	—	30 Sep 2023	13F
IEQ CAPITAL, LLC	13F	Company	0.48%	481,298	$54,146,025	—	30 Sep 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.48%	478,088	$53,784,900	—	30 Sep 2023	13F
FIRST TRUST ADVISORS LP	13F	Company	0.46%	463,640	$52,159,500	—	30 Sep 2023	13F
Legal & General Group Plc	13F	Company	0.45%	448,148	$50,416,657	—	30 Sep 2023	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.45%	448,000	$50,400,000	—	30 Sep 2023	13F
ORBIMED ADVISORS LLC	13F	Company	0.41%	415,900	$46,788,750	—	30 Sep 2023	13F
Russell Investments Group, Ltd.	13F	Company	0.41%	413,843	$46,560,549	—	30 Sep 2023	13F
JENNISON ASSOCIATES LLC	13F	Company	0.41%	409,475	$46,065,939	—	30 Sep 2023	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.39%	391,585	$44,053,312	—	30 Sep 2023	13F

Institutional Holders of Neurocrine Biosciences Inc - Common Stock (NBIX) as of Q4 2023

As of 31 Dec 2023, Neurocrine Biosciences Inc - Common Stock (NBIX) was held by 545 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,326,586 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Bellevue Group AG, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 547 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

508

Q4 2023 holders

545

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.